Gri Bio Etf Market Value
| GRI Etf | USD 0.69 0.05 7.81% |
| Symbol | GRI |
The market value of GRI Bio is measured differently than its book value, which is the value of GRI that is recorded on the company's balance sheet. Investors also form their own opinion of GRI Bio's value that differs from its market value or its book value, called intrinsic value, which is GRI Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GRI Bio's market value can be influenced by many factors that don't directly affect GRI Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GRI Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if GRI Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GRI Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GRI Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GRI Bio's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GRI Bio.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in GRI Bio on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding GRI Bio or generate 0.0% return on investment in GRI Bio over 720 days. GRI Bio is related to or competes with Terns Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, X4 Pharmaceuticals, Day One, Mereo BioPharma, and PDS Biotechnology. The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses... More
GRI Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GRI Bio's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GRI Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.06 | |||
| Information Ratio | 0.0838 | |||
| Maximum Drawdown | 154.1 | |||
| Value At Risk | (16.49) | |||
| Potential Upside | 24.32 |
GRI Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GRI Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GRI Bio's standard deviation. In reality, there are many statistical measures that can use GRI Bio historical prices to predict the future GRI Bio's volatility.| Risk Adjusted Performance | 0.078 | |||
| Jensen Alpha | 1.82 | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.1567 | |||
| Treynor Ratio | (1.15) |
GRI Bio Backtested Returns
GRI Bio is out of control given 3 months investment horizon. GRI Bio holds Efficiency (Sharpe) Ratio of 0.0894, which attests that the entity had a 0.0894% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.71% are justified by taking the suggested risk. Use GRI Bio Risk Adjusted Performance of 0.078, semi deviation of 8.26, and Market Risk Adjusted Performance of (1.14) to evaluate company specific risk that cannot be diversified away. The etf retains a Market Volatility (i.e., Beta) of -1.45, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning GRI Bio are expected to decrease by larger amounts. On the other hand, during market turmoil, GRI Bio is expected to outperform it.
Auto-correlation | 0.45 |
Average predictability
GRI Bio has average predictability. Overlapping area represents the amount of predictability between GRI Bio time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GRI Bio price movement. The serial correlation of 0.45 indicates that just about 45.0% of current GRI Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.45 | |
| Spearman Rank Test | 0.85 | |
| Residual Average | 0.0 | |
| Price Variance | 186.58 |
GRI Bio lagged returns against current returns
Autocorrelation, which is GRI Bio etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GRI Bio's etf expected returns. We can calculate the autocorrelation of GRI Bio returns to help us make a trade decision. For example, suppose you find that GRI Bio has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GRI Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GRI Bio etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GRI Bio etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GRI Bio etf over time.
Current vs Lagged Prices |
| Timeline |
GRI Bio Lagged Returns
When evaluating GRI Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GRI Bio etf have on its future price. GRI Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GRI Bio autocorrelation shows the relationship between GRI Bio etf current value and its past values and can show if there is a momentum factor associated with investing in GRI Bio.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.